TFF Pharmaceuticals (TFFP)
(Real Time Quote from BATS)
$2.30 USD
+0.01 (0.44%)
Updated May 21, 2024 12:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/20/24 |
---|---|
Current Quarter | -1.70 |
EPS Last Quarter | -2.40 |
Last EPS Surprise | -9.09% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.51 |
Next Year | -6.50 |
EPS (TTM) | -10.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.15M | 0.15M | 0.65M | 0.60M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.15M | 0.15M | 0.65M | 0.60M |
Low Estimate | 0.15M | 0.15M | 0.65M | 0.60M |
Year ago Sales | 0.33M | 0.24M | 0.73M | 0.65M |
Year over Year Growth Est. | -54.55% | -37.50% | -11.32% | -7.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.70 | -1.35 | -6.51 | -6.50 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.70 | -1.35 | -6.51 | -6.50 |
High Estimate | -1.70 | -1.35 | -6.51 | -6.50 |
Low Estimate | -1.70 | -1.35 | -6.51 | -6.50 |
Year ago EPS | -3.50 | -2.25 | -11.85 | -6.51 |
Year over Year Growth Est. | 51.43% | 40.00% | 45.06% | 0.15% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.70 | -1.35 | -6.51 | -6.50 |
7 Days Ago | -2.11 | -1.53 | -7.28 | -7.51 |
30 Days Ago | -2.11 | -1.53 | -7.28 | -7.51 |
60 Days Ago | -1.75 | -1.75 | -7.50 | -7.25 |
90 Days Ago | -1.75 | -1.75 | -7.50 | -7.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.70 | -1.35 | -6.51 | -6.50 |
Zacks Consensus Estimate | -1.70 | -1.35 | -6.51 | -6.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.40 | -2.01 | -2.25 | -3.50 | NA |
Estimate | -2.20 | -2.00 | -2.75 | -5.00 | NA |
Difference | -0.20 | -0.01 | 0.50 | 1.50 | 0.45 |
Surprise | -9.09% | -0.50% | 18.18% | 30.00% | 9.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more